Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
54
EME Quote, Financials, Valuation and Earnings
Last price:
$386.48
Seasonality move
:
10.86%
Day range:
$384.33 - $398.65
52-week range:
$319.49 - $545.30
Dividend yield:
0.25%
P/E ratio:
18.34x
P/S ratio:
1.27x
P/B ratio:
6.12x
Volume:
391.2K
Avg. volume:
529.8K
1-year change:
20.27%
Market cap:
$18B
Revenue:
$14.6B
EPS (TTM):
$21.54
EMCOR Group Number of Institutional Trades
EMCOR Group Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$14.2B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$30.9B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EMCOR Group Institutional Ownership
-
What Percentage Of EME Is Owned by Institutions?
-- of EME is owned by institutions.
-
How Many Institutions Own EME Shares?
EMCOR Group stock is owned by 1,611 institutional shareholders at this time.
-
Have Institutions Been Buying EME Stock?
Yes, institutions have bought 16.8M shares of EME in the last quarter.
-
Have Institutions Been Selling EME Stock?
Yes, institutions have sold 35.4M shares of EME over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
